Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03815565
Other study ID # 65821217.5.0000.8066
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 28, 2017
Est. completion date January 8, 2021

Study information

Verified date February 2020
Source Hospital Municipal Miguel Couto
Contact Rafael Linhares
Phone +55 21 981436088
Email rafaellinhares@me.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the continuous femoral block between levobupivacaine 0.125% and ropivacaine 0.2% in patients with proximal femoral fracture.These patients will be divided into 2 groups of 35 patients, one L group (levobupivacaine 0.125%) and one R group (ropivacaine 0.2%) distributed randomly, receiving continuous infusion through patient controlled analgesia (PCA) pump with the following parameters: infusion 5 ml / h, bolus 5 ml, lockout 30 min.


Description:

Pain is associated with neurohormonal stress, myocardial ischemia and delayed mobilization, thus being able to increase the hospitalization time and associated with increased postoperative mortality. Regional anesthesia through simple or continuous femoral nerve block are options for analgesia in patients with femoral fracture, as well as analgesia by venous opioids. A potential benefit of regional anesthesia is precisely to avoid the use of opioids and other general anesthetics, which in turn are also closely related to postoperative delirium. Continuous femoral block, since the preoperative period, is associated with the reduction of acute pain and opioid consumption, in patients with femoral neck fractures. There are few studies available in the literature comparing analgesic equipotency between levobupivacaine and ropivacaine in peripheral nerve blocks. In none of them, the peripheral analgesia in the femoral nerve, for proximal femoral fracture was compared.


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date January 8, 2021
Est. primary completion date August 8, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria:

- 70 years old or more

- patients with femur fracture

- physical status risk American Society of Anesthesiologists (ASA) P1 - P3

Exclusion Criteria:

- physical status ASA P4

- patients with BMI > 35

- systemic infection

- Injury or infection at the site of installation of the femoral perineural catheter

- Catheter displacement of the perineural site

- Montreal Cognitive Assessment (MoCA) < 26

- Patients operated before 24 hours of hospital admission

Study Design


Intervention

Procedure:
continuous femoral block
infusion of anesthetic by PCA pump

Locations

Country Name City State
Brazil Rafael M Linhares Rio de Janeiro

Sponsors (1)

Lead Sponsor Collaborator
Hospital Municipal Miguel Couto

Country where clinical trial is conducted

Brazil, 

References & Publications (4)

Joshi G, Gandhi K, Shah N, Gadsden J, Corman SL. Peripheral nerve blocks in the management of postoperative pain: challenges and opportunities. J Clin Anesth. 2016 Dec;35:524-529. doi: 10.1016/j.jclinane.2016.08.041. Epub 2016 Oct 20. Review. — View Citation

Morrison RS, Magaziner J, McLaughlin MA, Orosz G, Silberzweig SB, Koval KJ, Siu AL. The impact of post-operative pain on outcomes following hip fracture. Pain. 2003 Jun;103(3):303-11. — View Citation

Ritcey B, Pageau P, Woo MY, Perry JJ. Regional Nerve Blocks For Hip and Femoral Neck Fractures in the Emergency Department: A Systematic Review. CJEM. 2016 Jan;18(1):37-47. doi: 10.1017/cem.2015.75. Epub 2015 Sep 2. Review. — View Citation

Szucs S, Iohom G, O'Donnell B, Sajgalik P, Ahmad I, Salah N, Shorten G. Analgesic efficacy of continuous femoral nerve block commenced prior to operative fixation of fractured neck of femur. Perioper Med (Lond). 2012 Jun 27;1:4. doi: 10.1186/2047-0525-1-4 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary intensity of individual pain episodes Self report pain intensity in the preoperative period. Scored 0-10 (0 = no pain; 10 = pain as bad as can be) 6 hours after hospital admission
Secondary Number of PCA firing in each patient at time of evaluation of pain 72 hours
Secondary Degree of satisfaction with analgesic therapy using the 5-point rating scale (very dissatisfied, dissatisfied, neutral, satisfied or very pleased) up to 72 hours - at the moment of surgery; or at the end of 72 hours
Secondary Quality of sleep very good, good, bad and very bad up to 72 hours
Secondary the cost of analgesic therapy including catheters, PCA and medication in each patient up to 72 hours
Secondary adverse event paresthesia, nausea, vomiting, ringing in the ear, metallic taste, convulsion or cardiac arrest up to 72 hours
See also
  Status Clinical Trial Phase
Completed NCT02507609 - Deep Neuromuscular Block on Cytokines Release and Postoperative Delirium N/A
Completed NCT03906864 - Care Pathway for Sub-acute Hip Rehabilitation N/A
Recruiting NCT04063891 - Vibration Therapy as an Intervention for Enhancing Trochanteric Hip Fracture Healing in Elderly Patients N/A
Completed NCT05039879 - Life Improving Factors After a Hip Fracture
Not yet recruiting NCT03887494 - Study of the Impact of the Femoral Implant "Y-strut" on Lytic Bone Metastases of the Femoral Neck (WAZA-ARY) N/A
Terminated NCT03065101 - Trigen InterTAN vs Sliding Hip Screw RCT N/A
Completed NCT03545347 - Physiotherapy, Nutritional Supplement and Anabolic Steroids in Rehabilitation of Patients With Hip Fracture. Phase 2
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05971173 - Nutritional Optimization and Bone Health Management for Older Adults Undergoing Hip Fracture Surgery Early Phase 1
Active, not recruiting NCT04957251 - Anterior vs Posterior Approach for Hip Hemiarthroplasty N/A
Terminated NCT04372966 - Uncemented Versus Cemented Total Hip Arthroplasty for Displaced Intracapsular Hip Fractures N/A
Withdrawn NCT05030688 - Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty N/A
Completed NCT04424186 - 'Rehabilitation for Life' N/A
Not yet recruiting NCT04183075 - Impact of a Nutritional Supplement on the Recovery of the Nutritional Status of Patients With Spontaneous Hip Fracture N/A
Withdrawn NCT05518279 - Early Administration Of Tranexamic Acid And Acute Blood Loss In Patients With Hip Fractures Phase 3
Not yet recruiting NCT02892968 - ED Ultrasonographic Regional Anesthesia to Prevent Incident Delirium in Hip Fracture Patients N/A
Not yet recruiting NCT02223572 - Secondary Fracture Prevention in Patients Who Suffered From Osteoporotic Fracture N/A
Active, not recruiting NCT02247791 - Uncemented Compared to Cemented Femoral Stems in Total Hip Arthroplasty N/A
Completed NCT00746876 - Unipolar or Bipolar Hemiarthroplasty in the Treatment of Displaced Femoral Neck Fractures. N/A
Completed NCT00058864 - The HIP Impact Protection Program (HIP PRO) N/A